| 注册
首页|期刊导航|中国中西医结合外科杂志|树突状细胞疫苗联合细胞因子诱导的杀伤细胞治疗用于预防结直肠癌术后复发转移的临床疗效观察

树突状细胞疫苗联合细胞因子诱导的杀伤细胞治疗用于预防结直肠癌术后复发转移的临床疗效观察

牛静秀 张利红 李佳丽 朱慧 庞雁 李维廉

中国中西医结合外科杂志2016,Vol.22Issue(2):112-116,5.
中国中西医结合外科杂志2016,Vol.22Issue(2):112-116,5.DOI:10.3969/j.issn.1007-6948.2016.02.002

树突状细胞疫苗联合细胞因子诱导的杀伤细胞治疗用于预防结直肠癌术后复发转移的临床疗效观察

Clinical Effects of Immunotherapy with Dendritic Cell Vaccine and Ctokine-induced Killer Cells in Pre? vention of Recurrence and Metastasis for post-Surgery Colorectal Cancer Patients

牛静秀 1张利红 2李佳丽 1朱慧 1庞雁 1李维廉1

作者信息

  • 1. 天津市人民医院肿瘤科 天津 300121
  • 2. 南开大学医学院 天津 300073
  • 折叠

摘要

Abstract

Objective To evaluate the clinical effects of immunotherapy with dendritic cells (DC) and cyto?kine-induced Killer (CIK) cells on prevention of recurrence and metastasis in post-surgery patients with colorec?tal cancer (CRC). Methods A total of 74 post-surgery patients with CRC were randomly divided into two groups. 24 cases who received immunotherapy with DC and CIK were defined as group I, 50 cases who did not received the immunotherapy were defined as group NI. Delayed type hypersensitivity (DTH) skin test results and fever were abserved in Group I. Quality of life (QOL) and disease-free survival (DFS) were analyzed in both groups. Results Positive rates of DTH and fever were 12/24(50.00%)and 8/24(33.33%)respectively in group I. Quality of life (QOL) by Karnofsky in group I was 8/24(33.33%)which was higher than that in group NI(19/50,18.00%, χ2=7.063 P=0.029). DFS in group I (298 days) was longer than DFS in group NI (200 days, χ2=4.304 P=0.038). Conclusion Immunotherapy with DC and CIK maybe improve QOL and prolong DFS in post-surgery CRC.

关键词

结直肠癌/无病生存期/树突状细胞/细胞因子诱导杀伤细胞

Key words

Colorectal cancer/disease-free sur?vival/dendritic cells/cytokine-induced killer cells

分类

医药卫生

引用本文复制引用

牛静秀,张利红,李佳丽,朱慧,庞雁,李维廉..树突状细胞疫苗联合细胞因子诱导的杀伤细胞治疗用于预防结直肠癌术后复发转移的临床疗效观察[J].中国中西医结合外科杂志,2016,22(2):112-116,5.

基金项目

天津市科技计划项目(12ZCDZSY17100) (12ZCDZSY17100)

中国中西医结合外科杂志

OACSTPCD

1007-6948

访问量0
|
下载量0
段落导航相关论文